全球中央实验室市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

预计到2030年，全球中心实验室市场需求将从2022年的40.4亿美元增长至72亿美元，2023-2030年复合年增长率为7.5%。

中心实验室通常与制药公司、合同研究组织（CRO）或学术机构签订合同，为分布在不同地点的多个临床试验机构进行实验室测试。使用中心实验室的目的是确保样本分析的标准化和一致性，最大限度地减少每个试验点自行检测可能出现的差异。

市场动态：

制药行业正在投入巨资研发新药和新疗法，从而导致对实验室服务的需求增加。临床试验对于药物开发过程至关重要。中心实验室可提供一系列服务来支持临床试验，如样本采集、处理和分析。此外，个性化医疗需要更复杂的实验室检测方法，而中心实验室可以提供这种服务。中心实验室正在采用自动化和人工智能技术来提高效率和准确性。这导致对其服务的需求增加。然而，医疗保健行业受到严格的监管，这可能使中心实验室的运营变得困难且成本高昂。此外，医院和诊所越来越多地提供实验室服务，这可能会对市场产生负面影响。

本研究涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构，评估全球范围内的竞争吸引力。此外，这些工具还对全球中心实验室市场的各个细分市场进行了全面评估。中心实验室行业的增长和趋势为本研究提供了整体方法。

区域分析：

该部分涵盖了区域前景，重点分析了北美、欧洲、亚太、拉美、中东和非洲地区对中心实验室市场的当前和未来需求。此外，该部分还重点分析了所有主要地区各个应用领域的需求、估计和预测。

该研究还涵盖了市场主要参与者的综合概况以及全球竞争格局的深入分析。中心实验室市场的主要参与者包括：ACM Global Laboratories、Labconnect、Cerba Research、Eurofins Scientific、Medicover Integrated Clinical Services、Versiti、A.P. Møller Holding A/S、Ampersand Capital Partners、Lambda Therapeutic Research Ltd、Cirion Biopharma Research Inc.本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制服务。

目 录

第一章：前言

• 说明
  • 目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第三章：中心实验室-行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按服务分类的市场吸引力分析
  • 按最终用途的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：全球中心实验室市场分析：按服务分类

• 服务概述
• 历史和预测数据
• 服务分析
• 基因服务
• 生物标记服务
• 微生物学服务
• 解剖病理学/组织学
• 标本管理和储存
• 特殊化学服务
• 其他

第六章：全球中心实验室市场分析：按最终用途分类

• 终端用途概述
• 历史和预测数据
• 按最终用途分析
• 制药公司
• 生物技术公司
• 学术研究机构

第七章 ：全球中心实验室市场分析：按地域

• 地区展望
• 地区介绍
• 北美销售分析
  • 概述、历史和预测数据 销售分析
  • 北美地区销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据 销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据 销售分析
  • 亚太地区细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据 销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据 销售分析
  • 中东及非洲地区销售分析
  • 中东及非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第八章 : 中心实验室企业竞争格局

• 中心实验室市场竞争
• 合伙/合作/协议
• 合并与收购
• 新产品发布
• 其他发展

第九章 : 公司概况

• 顶级公司市场份额分析
• 市场集中度
• ACM Global Laboratories
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Labconnect
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Cerba Research
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Eurofins Scientific
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Medicover Integrated Clinical Services
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Versiti
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• A.P. Møller Holding A/S
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Ampersand Capital Partners
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Lambda Therapeutic Research Ltd
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Cirion Biopharma Research Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

The global demand for Central Lab Market is presumed to reach the market size of nearly USD 7.2 BN by 2030 from USD 4.04 BN in 2022 with a CAGR of 7.5% under the study period 2023 - 2030.

Central labs are typically contracted by pharmaceutical companies, contract research organizations (CROs), or academic institutions to conduct laboratory testing for multiple clinical trial sites spread across different locations. The purpose of using a central lab is to ensure standardized and consistent analysis of samples, minimizing variations that could occur if each site performed its own testing.

MARKET DYNAMICS:

The pharmaceutical industry is investing heavily in R&D to develop new drugs and treatments, leading to an increased demand for laboratory services. Clinical trials are critical for the drug development process. Central labs can provide a range of services to support clinical trials, such as sample collection, processing, and analysis. Moreover, personalized medicine requires a more sophisticated approach to laboratory testing, which central labs can provide. Central labs are adopting automation and artificial intelligence to improve efficiency and accuracy. This is leading to increased demand for their services. However, the healthcare industry is subject to stringent regulations, which can make central labs operation difficult and costly. Also, hospitals and clinics are increasingly offering laboratory services which may affect the market negatively.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of central lab. The growth and trends of central lab industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the central lab market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Services

• Genetic Services
• Biomarker Services
• Microbiology Services
• Anatomic Pathology/Histology
• Specimen Management & Storage
• Special Chemistry Services
• Others

By End-Use

• Pharmaceutical Companies
• Biotechnology Companies
• Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Central Lab market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the central lab market include ACM Global Laboratories; Labconnect; Cerba Research; Eurofins Scientific; Medicover Integrated Clinical Services; Versiti; A.P. Møller Holding A/S; Ampersand Capital Partners; Lambda Therapeutic Research Ltd; Cirion Biopharma Research Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CENTRAL LAB - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Services
  • 3.7.2 Market Attractiveness Analysis By End-use
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY SERVICES

• 5.1 Overview by Services
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Services
• 5.4 Genetic Services Historic and Forecast Sales by Regions
• 5.5 Biomarker Services Historic and Forecast Sales by Regions
• 5.6 Microbiology Services Historic and Forecast Sales by Regions
• 5.7 Anatomic Pathology/Histology Historic and Forecast Sales by Regions
• 5.8 Specimen Management & Storage Historic and Forecast Sales by Regions
• 5.9 Special Chemistry Services Historic and Forecast Sales by Regions
• 5.10. Others Historic and Forecast Sales by Regions

6 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY END-USE

• 6.1 Overview by End-use
• 6.2 Historical and Forecast Data
• 6.3 Analysis by End-use
• 6.4 Pharmaceutical Companies Historic and Forecast Sales by Regions
• 6.5 Biotechnology Companies Historic and Forecast Sales by Regions
• 6.6 Academic & Research Institutes Historic and Forecast Sales by Regions

7 . GLOBAL CENTRAL LAB MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE CENTRAL LAB COMPANIES

• 8.1. Central Lab Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF CENTRAL LAB INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. ACM Global Laboratories
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Labconnect
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Cerba Research
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Eurofins Scientific
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Medicover Integrated Clinical Services
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Versiti
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. A.P. Møller Holding A/S
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Ampersand Capital Partners
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Lambda Therapeutic Research Ltd
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Cirion Biopharma Research Inc.
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Services (USD MN)
• Genetic Services Market Sales by Geography (USD MN)
• Biomarker Services Market Sales by Geography (USD MN)
• Microbiology Services Market Sales by Geography (USD MN)
• Anatomic Pathology/Histology Market Sales by Geography (USD MN)
• Specimen Management & Storage Market Sales by Geography (USD MN)
• Special Chemistry Services Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biotechnology Companies Market Sales by Geography (USD MN)
• Academic & Research Institutes Market Sales by Geography (USD MN)
• Global Central Lab Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Central Lab
• Market Research Process
• Market Research Methodology
• Global Central Lab Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Services
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Services (USD MN)
• Genetic Services Market Sales by Geography (USD MN)
• Biomarker Services Market Sales by Geography (USD MN)
• Microbiology Services Market Sales by Geography (USD MN)
• Anatomic Pathology/Histology Market Sales by Geography (USD MN)
• Specimen Management & Storage Market Sales by Geography (USD MN)
• Special Chemistry Services Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Pharmaceutical Companies Market Sales by Geography (USD MN)
• Biotechnology Companies Market Sales by Geography (USD MN)
• Academic & Research Institutes Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.